ImmuCell Corporation (ICCC)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
10. 56
-0.19
-1.7674%
$
88.66M Market Cap
- P/E Ratio
- Div Yield
9,900 Volume
0 Eps
$ 10.75
Previous Close 
Want to track ICCC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmuCell Corporation (ICCC) Statistics
Valuation metrics
Market Cap 88.66M
Enterprise value 92.25M
Trailing P/E (ttm) 115.84
Forward P/E -
PEG ratio -0.3
Price/Sales (ttm) 2.89
Price/Book (mrq) 2.83
Enterprise Value/Revenue 3.01
Enterprise Value/EBITDA 26.09
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.9K
Average volume (90 days) 22.38K
Price summary
52-Week low 4.52
52-Week high 12.1
Beta -
50-Day moving average 9.9
200-Day moving average 8.5
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 25 Jul 1990
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.03%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.98
Total debt (mrq) -
Total Debt/Equity (mrq) 0.4
Current ratio (mrq) 4.75%
Book value per share (mrq) 3.46
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
